GO:0034138 toll-like receptor 3 signaling pathway: Antiviral Innate Immunity, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034138 (toll-like receptor 3 signaling pathway) is the biological process initiated when double-stranded RNA (dsRNA) binds the endolysosomal receptor TLR3.
• TLR3 is the founding member of the TLR family shown to recognize dsRNA and activate NF-kappaB; its signaling is a core antiviral innate immune mechanism.
• The pathway proceeds through TLR3 dimerization, TRIF adaptor recruitment, and activation of IRF3 and NF-kappaB, driving type I interferon and inflammatory cytokine production.
• Nucleoside modification of RNA can suppress TLR3 recognition, linking RNA chemistry to immune evasion and therapeutic design.
• Viruses such as human papillomavirus (HPV) and SARS-CoV-2 modulate or are affected by TLR3 signaling, making the pathway a disease-relevant target.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect TLR3 pathway gene function and to validate drug candidates.
Description
The toll-like receptor 3 (TLR3) signaling pathway (GO:0034138) is a biological process that begins when a ligand binds the endolysosomal receptor TLR3. This pathway is a central component of antiviral innate immunity, translating the detection of double-stranded RNA (dsRNA) into transcriptional programs that restrict viral replication. Since its initial characterization as a dsRNA sensor that activates NF-kappaB, TLR3 has become a paradigm for understanding how endosomal nucleic acid sensing couples to interferon and cytokine responses. Researchers study GO:0034138 because it sits at the interface of host defense, autoinflammation, and viral immune evasion, and because its dysregulation is implicated in diverse pathologies ranging from viral infection to cataract-related mechanisms. The pathway is also a target for pharmacological modulation, as illustrated by compounds such as famotidine that inhibit TLR3-mediated inflammatory signaling in SARS-CoV-2 infection. Understanding the molecular steps, regulatory checkpoints, and disease associations of TLR3 signaling is therefore essential for both basic immunology and translational research.
toll-like receptor 3 signaling pathway At A Glance
| GO ID | GO:0034138 |
|---|---|
| GO term | toll-like receptor 3 signaling pathway |
| Ontology | biological_process |
| Synonym | TLR3 signaling pathway; toll-like receptor 3 signalling pathway |
| Major function | Initiation of molecular signals upon ligand binding to endolysosomal TLR3, leading to NF-kappaB and IRF3 activation |
| Ligand | Double-stranded RNA (dsRNA) |
| Key adaptor | TRIF (TICAM1) |
| Downstream effectors | NF-kappaB, IRF3, type I interferons, inflammatory cytokines |
| Cellular location | Endolysosomal membrane |
What Is GO:0034138?
According to the Gene Ontology, GO:0034138 (toll-like receptor 3 signaling pathway) is defined as the series of molecular signals initiated by a ligand binding to the endolysosomal toll-like receptor 3. In practice, this means the process spans ligand recognition by TLR3 within endosomes, receptor activation, recruitment of the adaptor TRIF, and downstream signaling that culminates in the activation of transcription factors such as NF-kappaB and IRF3. The pathway is synonymous with TLR3 signaling pathway and toll-like receptor 3 signalling pathway, and it is classified as a biological_process. Its core function is to convert dsRNA detection into an antiviral and inflammatory transcriptional response.
Why Is toll-like receptor 3 signaling pathway Important in Cell Biology?
GO:0034138 is important because it defines the molecular route by which cells detect dsRNA, a signature of many viral infections, and mount an antiviral and inflammatory response. This pathway is a cornerstone of innate immunity and is frequently targeted or subverted by viruses, as shown for HPV E1 proteins that inhibit TLR3-TRIF signaling among other innate pathways. Its activity also contributes to inflammatory pathology, and pharmacological inhibition of TLR3-mediated signaling can reduce inflammation in viral infection models. Moreover, TLR3 signaling has been linked to non-infectious conditions such as cataract-related mechanisms via the Jagged-1/Notch pathway and to endometrial inflammatory cytokine production, underscoring its broad physiological and pathological relevance.
• Provides the primary innate immune sensing mechanism for double-stranded RNA, a common viral replication intermediate.
• Drives NF-kappaB and IRF3 activation, leading to type I interferon and pro-inflammatory cytokine production.
• Is a target of viral immune evasion, as HPV E1 proteins inhibit TLR3-TRIF signaling.
• Modulates inflammatory responses in SARS-CoV-2 infection, with pharmacological inhibitors such as famotidine reducing TLR3-mediated signaling.
• Has been implicated in cataract-related mechanisms through the Jagged-1/Notch pathway.
• Contributes to inflammatory cytokine production in endometrial stromal cells when serpin A1 is inhibited.
• Nucleoside modification of RNA can suppress TLR3 recognition, affecting immune activation by therapeutic RNA.
• Serves as a model pathway for understanding endosomal nucleic acid sensing and adaptor usage in TLR biology.
• Offers opportunities for CRISPR-based functional genomics to identify modulators of antiviral immunity.
• Is relevant to drug discovery, as small molecules can modulate TLR3 signaling and downstream inflammation.
What Happens During toll-like receptor 3 signaling pathway?
Ligand recognition and receptor activation
In simple terms: TLR3 detects double-stranded RNA inside the cell's endosomes, like a security guard recognizing a virus-specific barcode.
The pathway is initiated when double-stranded RNA (dsRNA) binds to the endolysosomal toll-like receptor 3 (TLR3). TLR3 was identified as a receptor that recognizes dsRNA and activates NF-kappaB. Ligand binding promotes receptor dimerization and conformational changes that are required for signaling. The recognition event is sensitive to RNA modifications, as nucleoside-modified RNA can suppress TLR3 activation. This step is the defining trigger for GO:0034138 and determines the specificity of the downstream response.
Adaptor recruitment and signalosome assembly
In simple terms: Once TLR3 is activated, it recruits a molecular bridge called TRIF to relay the signal inside the cell.
Upon activation, TLR3 recruits the adaptor protein TRIF (TICAM1), which is the sole TIR-domain-containing adaptor used by TLR3. TRIF nucleates a signaling complex that includes TRAF3, TRAF6, and other factors, leading to the activation of downstream kinases. This assembly is a critical checkpoint because it links receptor engagement to both IRF3 and NF-kappaB branches. The TLR3-TRIF axis is a target of viral inhibition, as HPV E1 proteins can block TLR3-TRIF signaling.
Activation of IRF3 and type I interferon production
In simple terms: The signal activates IRF3, a transcription factor that turns on antiviral interferon genes.
TRIF recruitment leads to the activation of TBK1 and IKKepsilon, which phosphorylate IRF3, causing its dimerization and nuclear translocation. Nuclear IRF3 induces the transcription of type I interferon genes, which are key antiviral effectors. This branch is essential for the antiviral innate immune response and is a hallmark of TLR3 signaling. Suppression of this branch by viral proteins, such as HPV E1, contributes to immune evasion.
NF-kappaB activation and inflammatory cytokine induction
In simple terms: The pathway also switches on NF-kappaB, which drives inflammation and immune cell recruitment.
In parallel to IRF3 activation, TRIF signaling activates the IKK complex, leading to IkappaB degradation and NF-kappaB nuclear translocation. NF-kappaB induces pro-inflammatory cytokines and chemokines, amplifying the immune response. This branch was part of the original description of TLR3 as a dsRNA receptor that activates NF-kappaB. Inflammatory output from this pathway can be modulated pharmacologically, as shown by famotidine inhibition of TLR3-mediated inflammatory signaling in SARS-CoV-2 infection.
Regulation and negative feedback
In simple terms: The pathway has brakes to prevent excessive inflammation, including regulatory molecules and RNA modifications.
TLR3 signaling is tightly regulated to avoid harmful overactivation. Negative regulators and post-translational modifications fine-tune the strength and duration of the response. Nucleoside modification of RNA can suppress TLR3 recognition, providing a natural mechanism to avoid aberrant activation by self-RNA. Additionally, inhibition of serpin A1 in endometrial stromal cells triggers TLR3 signaling and inflammatory cytokine production, illustrating how the pathway can be engaged indirectly. These regulatory layers are critical for maintaining immune homeostasis.
Key Genes Involved in GO:0034138 toll-like receptor 3 signaling pathway
The following genes and proteins are core components or modulators of the toll-like receptor 3 signaling pathway (GO:0034138), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR3 | Endolysosomal receptor that binds dsRNA and initiates signaling | Central to antiviral innate immunity; target for KO and point-mutation studies |
| TICAM1 (TRIF) | Sole TIR-domain adaptor for TLR3; recruits downstream kinases | Essential for TLR3 signaling; knockout abolishes IRF3 and NF-kappaB activation |
| TRAF3 | Ubiquitin ligase involved in IRF3 activation downstream of TRIF | Modulates type I interferon production; studied via overexpression and KO |
| TRAF6 | Ubiquitin ligase involved in NF-kappaB activation downstream of TRIF | Regulates inflammatory cytokine induction; target for functional studies |
| TBK1 | Kinase that phosphorylates IRF3 | Key node for interferon induction; point mutations affect kinase activity |
| IKBKE (IKKepsilon) | Kinase that phosphorylates IRF3 in parallel with TBK1 | Modulates IRF3 activation; studied in KO models |
| IRF3 | Transcription factor that induces type I interferon genes | Central effector of antiviral response; knockout reduces interferon output |
| NFKB1 | Transcription factor subunit driving inflammatory cytokine expression | Mediates NF-kappaB branch; knockout affects cytokine production |
| RELA | NF-kappaB subunit essential for inflammatory gene transcription | Target for point-mutation and overexpression studies |
| MAVS | Mitochondrial adaptor in RIG-I/MDA5 pathway; crosstalk with TLR3 | Viral evasion target; relevant to comparative pathway studies |
| RIG-I (DDX58) | Cytosolic dsRNA sensor; parallel to TLR3 | HPV E1 inhibits RIG-I/MDA5-MAVS; useful for pathway crosstalk |
| MDA5 (IFIH1) | Cytosolic dsRNA sensor; parallel to TLR3 | Inhibited by HPV E1; model for innate immune evasion |
| STING1 | Adaptor in cGAS-STING pathway; crosstalk with TLR3 | HPV E1 inhibits cGAS-STING; relevant to innate immunity networks |
| JAK1 | Kinase in JAK-STAT pathway downstream of interferon | HPV E1 inhibits JAK-STAT; links TLR3 to interferon signaling |
| STAT1 | Transcription factor mediating interferon responses | Downstream of TLR3-induced interferons; target for KO studies |
| SERPINA1 | Serine protease inhibitor; its inhibition triggers TLR3 signaling | Modulates inflammatory cytokine production in endometrial cells |
| JAG1 | Notch ligand linked to TLR3 regulation in cataract mechanisms | Potential crosstalk node; studied in TLR3-related cataract models |
| NOTCH1 | Notch receptor in Jagged-1/Notch pathway linked to TLR3 | Mediates TLR3 effects on cataract-related mechanisms |
How Is toll-like receptor 3 signaling pathway Regulated?
The toll-like receptor 3 signaling pathway is subject to multiple layers of regulation to prevent excessive or aberrant immune activation. Post-translational modifications, including ubiquitination and phosphorylation, control the stability and activity of key signaling components such as TRIF, TRAF3, and IRF3. Negative feedback mechanisms, including the induction of regulatory molecules, dampen the response after initial activation. RNA modifications also play a regulatory role: nucleoside-modified RNA is poorly recognized by TLR3, which helps explain how self-RNA is discriminated from viral RNA. In addition, indirect triggers such as inhibition of serpin A1 can stimulate TLR3 signaling and inflammatory cytokine production in endometrial stromal cells, indicating that the pathway can be engaged by changes in the protease inhibitor environment. Viral proteins, such as HPV E1, can inhibit TLR3-TRIF signaling as an immune evasion strategy, effectively acting as negative regulators of the pathway. These regulatory mechanisms ensure that TLR3 signaling is appropriately balanced between effective antiviral defense and avoidance of autoinflammation.
toll-like receptor 3 signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR3 | Antiviral innate immunity; SARS-CoV-2 inflammation | TLR3 knockout cell lines and primary immune cells |
| TICAM1 (TRIF) | TLR3 signaling deficiency; immune evasion | TRIF knockout models to abolish TLR3 signaling |
| IRF3 | Type I interferon deficiency; viral susceptibility | IRF3 knockout or point-mutation knock-in |
| SERPINA1 | Endometrial inflammation | SERPINA1 knockdown or inhibition in stromal cells |
| JAG1 | Cataract-related mechanisms | JAG1 overexpression or knockout in lens epithelial cells |
Viral infection and immune evasion
TLR3 signaling is a primary antiviral pathway, and many viruses have evolved mechanisms to inhibit it. Human papillomavirus (HPV) E1 proteins inhibit TLR3-TRIF signaling, among other innate immune pathways, to evade host defenses. In SARS-CoV-2 infection, TLR3-mediated inflammatory signaling contributes to pathology, and pharmacological inhibition with famotidine reduces this inflammatory response. These examples highlight the pathway as a therapeutic target and a determinant of viral pathogenesis.
Inflammatory and autoimmune conditions
Dysregulated TLR3 signaling can drive excessive inflammation. In endometrial stromal cells, inhibition of serpin A1 triggers TLR3 signaling and the production of inflammatory cytokines, linking the pathway to inflammatory conditions of the endometrium. The NF-kappaB branch of TLR3 signaling is a major contributor to cytokine production, and its overactivation is associated with inflammatory pathology. Modulating this pathway is therefore of interest for anti-inflammatory strategies.
Cataract and ocular biology
TLR3 has been implicated in cataract-related mechanisms via the Jagged-1/Notch signaling pathway. This suggests that TLR3 signaling can influence non-immune processes such as lens biology, potentially through crosstalk with Notch signaling. Further research is needed to fully define the mechanistic links, but the association expands the disease relevance of GO:0034138 beyond classical antiviral immunity.
From toll-like receptor 3 signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TLR3 mediate dsRNA-induced NF-kappaB activation? | TLR3 knockout cell line |
| Is TRIF required for TLR3-dependent IRF3 activation? | TICAM1 (TRIF) knockout |
| Does a specific point mutation in TLR3 affect ligand binding? | TLR3 point-mutation knock-in |
| Can overexpression of IRF3 enhance interferon production? | IRF3 overexpression cell line |
| Does tagged TLR3 localize to endosomes upon stimulation? | Tagged TLR3 knock-in |
| Does HPV E1 inhibit TLR3-TRIF signaling? | HPV E1 overexpression in TLR3-competent cells |
How to Study the toll-like receptor 3 signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript changes | Identify interferon and cytokine genes induced by TLR3 |
| Western blot | Protein phosphorylation and expression | Monitor IRF3 and NF-kappaB activation |
| Co-immunoprecipitation | Protein-protein interactions | Study TLR3-TRIF complex assembly |
| CRISPR knockout screen | Gene requirement for pathway activity | Discover modulators of TLR3 signaling |
| Fluorescence microscopy | Subcellular localization | Confirm endosomal TLR3 localization |
| Luciferase reporter assay | Transcription factor activity | Measure NF-kappaB and IRF3 activation |
| qRT-PCR | Specific gene expression | Quantify interferon and cytokine mRNAs |
| Flow cytometry | Cell surface and intracellular markers | Assess immune cell activation |
Transcriptomic profiling of TLR3 signaling
RNA sequencing (RNA-seq) is widely used to measure global gene expression changes following TLR3 activation, including type I interferon and inflammatory cytokine genes. This approach can identify novel downstream targets and regulatory networks of GO:0034138. In viral infection models, RNA-seq can reveal how pathogens modulate TLR3 signaling.
Protein interaction and signaling assays
Co-immunoprecipitation and Western blotting are used to study the assembly of the TLR3-TRIF signalosome and the activation of downstream kinases such as TBK1 and IRF3. Phospho-specific antibodies allow monitoring of IRF3 phosphorylation and NF-kappaB activation. These methods are essential for dissecting the molecular steps of the pathway.
Functional genomics with CRISPR screens
CRISPR knockout screens can identify genes that regulate TLR3 signaling, including positive and negative modulators. Such screens are particularly useful for uncovering viral evasion factors and host dependency factors. Libraries targeting kinases, ubiquitin ligases, and interferon-related genes can be applied to TLR3 reporter systems.
Imaging and localization studies
Fluorescence microscopy and live-cell imaging of tagged TLR3 can reveal its endosomal localization and trafficking upon ligand stimulation. These techniques help confirm the endolysosomal site of signaling initiation defined for GO:0034138. Co-localization with endosomal markers is a standard readout.
How CRISPR Can Be Used to Study GO:0034138 toll-like receptor 3 signaling pathway
Knockout
CRISPR knockout of TLR3, TICAM1 (TRIF), or downstream effectors such as IRF3 is used to definitively test their requirement in the toll-like receptor 3 signaling pathway. For example, TLR3 knockout cells fail to respond to dsRNA with NF-kappaB activation. TRIF knockout abolishes TLR3-dependent IRF3 phosphorylation. These models are foundational for assigning gene function to GO:0034138.
Point Mutation
Point-mutation knock-in can be used to dissect specific residues required for TLR3 signaling, such as phosphorylation sites in IRF3 or ubiquitination sites in TRIF. Such models allow precise structure-function analysis without completely eliminating the protein. They are valuable for understanding how disease-associated variants might alter pathway activity.
Knock-in
Tagged knock-in of TLR3 or TRIF (e.g., with fluorescent or affinity tags) enables visualization and biochemical isolation of the endogenous proteins. This approach preserves physiological expression levels and regulatory context. It is particularly useful for studying endosomal trafficking and signalosome assembly.
Overexpression
Overexpression of TLR3, TRIF, IRF3, or viral inhibitors such as HPV E1 is used to amplify pathway activity or to test dominant effects. For instance, HPV E1 overexpression inhibits TLR3-TRIF signaling, demonstrating viral evasion. Overexpression models are also used to screen for gain-of-function phenotypes.
How EDITGENE Supports toll-like receptor 3 signaling pathway Research
Researchers studying toll-like receptor 3 signaling pathway-related genes often need to determine whether a candidate gene is causally involved in dsRNA sensing, signal transduction, or inflammatory output. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional validation, from knockout to precise point mutations and overexpression, supported by library screening and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for toll-like receptor 3 signaling pathway research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TRAF6 Knockout HEK293 Cell Line | EDJ-KQ107 | Human | 7189 | Details Get a Quote |
| MAP3K7 Knockout HEK293 Cell Line | EDJ-KQ142 | Human | 6885 | Details Get a Quote |
| IKBKB Knockout HEK293 Cell Line | EDJ-KQ566 | Human | 3551 | Details Get a Quote |
| TICAM1 Knockout HEK293 Cell Line | EDJ-KQ593 | Human | 148022 | Details Get a Quote |
| IRF1 Knockout HEK293 Cell Line | EDJ-KQ1490 | Human | 3659 | Details Get a Quote |
| IRF2 Knockout HEK293 Cell Line | EDJ-KQ1668 | Human | 3660 | Details Get a Quote |
| HAVCR2 Knockout HEK293 Cell Line | EDJ-KQ2665 | Human | 84868 | Details Get a Quote |
| OAS1 Knockout HEK293 Cell Line | EDJ-KQ3650 | Human | 4938 | Details Get a Quote |
| RFTN1 Knockout HEK293 Cell Line | EDJ-KQ7873 | Human | 23180 | Details Get a Quote |
| UNC93B1 Knockout HEK293 Cell Line | EDJ-KQ8954 | Human | 81622 | Details Get a Quote |
| TNIP2 Knockout HEK293 Cell Line | EDJ-KQ11959 | Human | 79155 | Details Get a Quote |
| SCIMP Knockout HEK293 Cell Line | EDJ-KQ15188 | Human | 388325 | Details Get a Quote |
| TLR3 Knockout HEK293 Cell Line | EDJ-KQ15746 | Human | 7098 | Details Get a Quote |
| TNF Knockout HEK293 Cell Line | EDJ-KQ17672 | Human | 7124 | Details Get a Quote |
| TICAM1 Knockout HeLa Cell Line | EDJ-KQ18035 | Human | 148022 | Details Get a Quote |
Displaying Records 1 To 15 Of 60 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About toll-like receptor 3 signaling pathway
What is the toll-like receptor 3 signaling pathway?
It is the biological process (GO:0034138) initiated by ligand binding to endolysosomal TLR3, leading to NF-kappaB and IRF3 activation.
What genes are involved in toll-like receptor 3 signaling pathway?
Key genes include TLR3, TICAM1 (TRIF), TRAF3, TRAF6, TBK1, IKBKE, IRF3, NFKB1, and RELA.
What ligand activates TLR3?
Double-stranded RNA (dsRNA) is the ligand that activates TLR3.
Where does TLR3 signaling occur in the cell?
TLR3 is located in endolysosomal membranes, where it binds dsRNA and initiates signaling.
How does TLR3 activate NF-kappaB?
TLR3 recruits TRIF, which activates the IKK complex, leading to IkappaB degradation and NF-kappaB nuclear translocation.
What is the role of TRIF in TLR3 signaling?
TRIF (TICAM1) is the sole TIR-domain adaptor for TLR3 and is essential for both IRF3 and NF-kappaB activation.
Can viruses inhibit TLR3 signaling?
Yes, HPV E1 proteins inhibit TLR3-TRIF signaling as an immune evasion mechanism.
Is TLR3 signaling involved in COVID-19?
TLR3-mediated inflammatory signaling is implicated in SARS-CoV-2 infection, and famotidine inhibits this response.
How can I study TLR3 signaling with CRISPR?
Use knockout, point-mutation, knock-in, or overexpression models to test gene function in dsRNA response assays.
What diseases are linked to TLR3 signaling?
Viral infections, inflammatory conditions, and cataract-related mechanisms have been linked to TLR3 signaling.
Conclusion
The toll-like receptor 3 signaling pathway (GO:0034138) is a fundamental antiviral innate immune process that converts dsRNA recognition into interferon and inflammatory responses. Its core components, including TLR3, TRIF, and IRF3, are well defined, and its dysregulation or viral subversion contributes to a range of diseases. Continued research using CRISPR-based models and functional genomics will further clarify its regulatory mechanisms and therapeutic potential.
References
- 1. Chen Y et al.. 2021. Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses.. J Zhejiang Univ Sci B 22(8):609-632 PMID: 34414698
- 2. Karikó K et al.. 2005. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.. Immunity 23(2):165-75 PMID: 16111635
- 3. Takeda K et al.. 2004. TLR signaling pathways.. Semin Immunol 16(1):3-9 PMID: 14751757
- 4. Alexopoulou L et al.. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.. Nature 413(6857):732-8 PMID: 11607032
- 5. Mukherjee R et al.. 2021. Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection.. J Biol Chem 297(2):100925 PMID: 34214498
- 6. Xie W et al.. 2022. Toll-like receptor 3 gene regulates cataract-related mechanisms via the Jagged-1/Notch signaling pathway.. Bioengineered 13(6):14357-14367 PMID: 35758265
- 7. Li JX et al.. 2025. Human papillomavirus E1 proteins inhibit RIG-I/MDA5-MAVS, TLR3-TRIF, cGAS-STING, and JAK-STAT signaling pathways to evade innate antiviral immunity.. Front Immunol 16:1549766 PMID: 40330484
- 8. Kusama K et al.. 2022. Toll-like receptor signaling pathway triggered by inhibition of serpin A1 stimulates production of inflammatory cytokines by endometrial stromal cells.. Front Endocrinol (Lausanne) 13:966455 PMID: 36093086
